Skip to main content

Cognitive Difficulties Tied to Lower Return to Work After Breast Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 23, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Aug. 23, 2024 -- Return to work two years after a breast cancer diagnosis is associated with higher cognitive speed performance before and after treatment, according to a study published online Aug. 19 in JAMA Network Open.

Marie Lange, Ph.D., from Normandie Université UNICAEN in Caen, France, and colleagues examined whether cognition, assessed using objective and subjective scores, was associated with return to work two years after a breast cancer diagnosis. The analysis included 178 women with breast cancer.

The researchers found that 20.8 percent of women did not return to work at year 2. Returning to work was more likely among patients with a higher occupational class (i.e., professional) and less likely among those who had a mastectomy (24.1 versus 54.1 percent). There was an association between return to work at year 2 and lower overall cognitive impairment (1-point unit of increased odds ratio [1-pt OR], 0.32), higher working memory (1-pt OR, 2.06), higher processing speed (1-pt OR, 1.97), higher attention performance (1-pt OR, 1.63), higher perceived cognitive abilities (1-pt OR, 1.12), and lower depression (1-pt OR, 0.83). There were associations observed between return to work and higher processing speed (1-pt OR at baseline and year 1, 2.38 and 1.95, respectively), higher executive performance (1-pt ORs, 2.61 and 2.88, respectively), and lower physical fatigue (10-pt ORs, 0.81 and 0.84, respectively).

"Cognitive difficulties should be assessed before return to work to propose suitable management," the authors write.

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...

Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk

TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and...

Exercise, Rehab Services Can Be Integrated Into Breast Cancer Care

MONDAY, April 28, 2025 -- Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.